The Clorox Company $CLX Shares Bought by Nissay Asset Management Corp Japan ADV

by · The Cerbat Gem

Nissay Asset Management Corp Japan ADV increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 1.3% in the first quarter, HoldingsChannel.com reports. The firm owned 15,907 shares of the company’s stock after buying an additional 205 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Clorox were worth $2,342,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Wood Tarver Financial Group LLC purchased a new stake in Clorox during the 4th quarter worth approximately $31,000. GW&K Investment Management LLC increased its stake in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares in the last quarter. Roble Belko & Company Inc increased its stake in Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after buying an additional 211 shares in the last quarter. IMA Advisory Services Inc. purchased a new stake in Clorox during the 1st quarter worth approximately $58,000. Finally, Menard Financial Group LLC purchased a new stake in Clorox during the 4th quarter worth approximately $63,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Jefferies Financial Group cut their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. Barclays dropped their price target on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research report on Tuesday, July 15th. UBS Group dropped their price target on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research report on Thursday, July 17th. Wells Fargo & Company dropped their price target on Clorox from $138.00 to $130.00 and set an “equal weight” rating for the company in a research report on Friday. Finally, Morgan Stanley dropped their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $142.18.

Get Our Latest Stock Analysis on Clorox

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Clorox Trading Down 0.9%

Shares of Clorox stock opened at $125.88 on Tuesday. The firm has a market capitalization of $15.40 billion, a price-to-earnings ratio of 19.31, a PEG ratio of 1.02 and a beta of 0.52. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a 50 day moving average of $124.28 and a 200 day moving average of $132.99.

Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a $1.24 dividend. The ex-dividend date was Wednesday, August 13th. This is a positive change from Clorox’s previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a yield of 3.9%. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).